News for 'Aurobindo Pharma'

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

US regulator tightens drug approval norms

US regulator tightens drug approval norms

Rediff.com29 Jul 2013

Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics

Stocks You Must AVOID or EXIT

Stocks You Must AVOID or EXIT

Rediff.com26 Apr 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Ask Ajit: 'Help! I have inherited these stocks...'

Ask Ajit: 'Help! I have inherited these stocks...'

Rediff.com23 Nov 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Midcap index hits 2-month high but Sensex ends down 119 points

Midcap index hits 2-month high but Sensex ends down 119 points

Rediff.com30 Dec 2015

Investors remain cautious ahead of F&O expiry.

Ask Ajit: 'Advice for small-time investor'

Ask Ajit: 'Advice for small-time investor'

Rediff.com14 Jan 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Ask Gaurav: Your stock queries answered

Ask Gaurav: Your stock queries answered

Rediff.com25 Nov 2020

Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries.

Stocks you must buy, hold or exit in the New Year

Stocks you must buy, hold or exit in the New Year

Rediff.com26 Dec 2019

Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Are you still holding these stocks? Exit NOW

Are you still holding these stocks? Exit NOW

Rediff.com13 Dec 2019

Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.

Full Text: President's joint address to both houses of Parliament

Full Text: President's joint address to both houses of Parliament

Rediff.com31 Jan 2022

Here's the full text of President's Ram Nath Kovind's address to the joint sitting of both houses of Parliament on the first of Budget Session 2022.

Stocks that can offer you good returns

Stocks that can offer you good returns

Rediff.com27 Jun 2016

Analysts mostly prefer domestic plays beside select films with foreign exposure.

Stocks to create long-term wealth

Stocks to create long-term wealth

Rediff.com25 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

Stocks you must buy, hold or exit

Stocks you must buy, hold or exit

Rediff.com25 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries:

The corporate story of 2015: When minnows humbled the giants

The corporate story of 2015: When minnows humbled the giants

Rediff.com6 Jan 2016

T N Ninan lists a few David-Goliath encounters in the Indian markets, all of which make life interesting, though difficult if you are an investor looking for the next multi-bagger.

« Prev  |